185 related articles for article (PubMed ID: 6246130)
1. Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors.
De Larco JE; Todaro GJ
J Cell Physiol; 1980 Feb; 102(2):267-77. PubMed ID: 6246130
[TBL] [Abstract][Full Text] [Related]
2. Properties of a sarcoma-growth-factor-like peptide from cells transformed by a temperature-sensitive sarcoma virus.
De Larco JE; Preston YA; Todaro GJ
J Cell Physiol; 1981 Oct; 109(1):143-52. PubMed ID: 6276416
[TBL] [Abstract][Full Text] [Related]
3. Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors.
Todaro GJ; De Larco JE; Fryling CM
Fed Proc; 1982 Nov; 41(13):2996-3003. PubMed ID: 6292003
[TBL] [Abstract][Full Text] [Related]
4. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
5. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
Huang JS; Nishimura J; Huang SS; Deuel TF
J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation.
de Larco JE; Todaro GJ
J Cell Physiol; 1978 Mar; 94(3):335-42. PubMed ID: 304450
[TBL] [Abstract][Full Text] [Related]
7. Autocrine secretion of peptide growth factors by tumor cells.
Todaro GJ
Natl Cancer Inst Monogr; 1982; 60():139-47. PubMed ID: 6289103
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
Robinson RA; Branum EL; Volkenant ME; Moses HL
Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
[TBL] [Abstract][Full Text] [Related]
9. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
[TBL] [Abstract][Full Text] [Related]
10. Mouse embryonic transforming growth factors related to those isolated from tumor cells.
Twardzik DR; Ranchalis JE; Todaro GJ
Cancer Res; 1982 Feb; 42(2):590-3. PubMed ID: 6275982
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factors released from Kirsten sarcoma virus transformed cells do not compete for epidermal growth factor membrane receptors.
Chua CC; Geiman D; Ladda RL
J Cell Physiol; 1983 Oct; 117(1):116-22. PubMed ID: 6311845
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of morphogenesis and stimulation of vascular proliferation in embryonic tooth cultures by a sarcoma growth factor preparation.
Thesleff I; Ekblom P; Keski-Oja J
Cancer Res; 1983 Dec; 43(12 Pt 1):5902-9. PubMed ID: 6315220
[TBL] [Abstract][Full Text] [Related]
13. Factors in the rat submaxillary gland that stimulate growth of cultured glioma cells: identification and partial characterization.
McClure DB; Ohasa S; Sato GH
J Cell Physiol; 1981 May; 107(2):195-207. PubMed ID: 6972945
[TBL] [Abstract][Full Text] [Related]
14. Effects of retinoic acid on the binding and mitogenic activity of epidermal growth factor.
Jetten AM
J Cell Physiol; 1982 Mar; 110(3):235-40. PubMed ID: 6282898
[TBL] [Abstract][Full Text] [Related]
15. The purification of an acid- and heat-labile transforming growth factor from an avian sarcoma virus-transformed rat cell line.
Yamaoka K; Hirai R; Tsugita A; Mitsui H
J Cell Physiol; 1984 Jun; 119(3):307-14. PubMed ID: 6327732
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.
Cook PW; Ashton NM; Karkaria CE; Siess DC; Shipley GD
J Cell Physiol; 1995 May; 163(2):418-29. PubMed ID: 7706383
[TBL] [Abstract][Full Text] [Related]
17. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
18. Down-modulation of EGF receptors in cells transformed by the src oncogene.
Wasilenko WJ; Shawver LK; Weber MJ
J Cell Physiol; 1987 Jun; 131(3):450-7. PubMed ID: 3036890
[TBL] [Abstract][Full Text] [Related]
19. Subcellular structures involved in internalization and degradation of epidermal growth factor.
Fine RE; Goldenberg R; Sorrentino J; Herschman HR
J Supramol Struct Cell Biochem; 1981; 15(3):235-51. PubMed ID: 6267315
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB
Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
